Prevalence and Causes of Hyperuricemia in Children

Jatender Kumar1, Aarzoo Gupta2, Kapeel Dev3

  • 1Internal Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.

Cureus
|July 8, 2021
PubMed

Insights

Hyperuricemia affects over 26% of children locally, being more common in males and older children. Prompt identification and management of pediatric hyperuricemia are crucial for preventing long-term complications.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Biochemistry

Background:

  • Hyperuricemia in children lacks sufficient local data, necessitating research into its causes and risk factors.
  • Understanding pediatric hyperuricemia is vital for effective clinical management and risk stratification.

Purpose of the Study:

  • To determine the prevalence, causes, and risk factors of hyperuricemia in children within a local healthcare setting.
  • To provide data that aids pediatricians in identifying and managing at-risk children.

Main Methods:

  • A cross-sectional study involving 5000 children aged 1-14 years was conducted in tertiary care hospitals.
  • Uric acid levels were measured using a handheld device (UASure).
  • Data collected from January 2018 to December 2019.

Main Results:

  • A prevalence of 26.02% (n=1301) for hyperuricemia was observed.
  • Hyperuricemia was significantly more prevalent in males (65.49%) and older children (mean age 9 ± 2 years).
  • Gastroenteritis (23.98%), respiratory infections (23.14%), and asthma (15.45%) were the most common associated disorders.

Conclusions:

  • Hyperuricemia is highly prevalent in the pediatric population locally.
  • Routine screening for hyperuricemia is recommended for children with pre-existing conditions like congenital heart disease, asthma, epilepsy, and cancers.
  • Early management is essential to mitigate potential long-term complications of pediatric hyperuricemia.

Related Concept Videos

Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
184
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
178
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
179
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
47
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
395
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
50